MEDNAX, Inc. (MD)
| Market Cap | 1.49B |
| Revenue (ttm) | 1.96B |
| Net Income (ttm) | 84.26M |
| Shares Out | 84.35M |
| EPS (ttm) | 0.94 |
| PE Ratio | 18.79 |
| Forward PE | 7.57 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 257,007 |
| Open | 17.15 |
| Previous Close | 16.92 |
| Day's Range | 17.05 - 17.76 |
| 52-Week Range | 16.31 - 29.07 |
| Beta | 1.88 |
| Analysts | Sell |
| Price Target | 20.85 (+18.1%) |
| Earnings Date | Oct 26, 2022 |
About MD
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical... [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for MD stock is "Sell." The 12-month stock price forecast is 20.85, which is an increase of 18.06% from the latest price.
News
7 Cheap Stocks That Could Increase 10X by 2027
As I was preparing to write about cheap stocks to buy that could increase by ten times over the next few years, I wondered what measuring stick I should use to appropriately identify names that were dow...
Pediatrix Medical Group Comments on No Surprises Act Final Rule
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Comments on No Surprises Act Final Rule
Pediatrix (MD) Up 8% Since Q2 Earnings Release, Revenues Up Y/Y
Pediatrix's (MD) second-quarter results reflect growth in patient volumes. Adjusted EBITDA is expected within $260-$270 million for 2022.
Mednax (MD) Q2 Earnings Match Estimates
Mednax (MD) delivered earnings and revenue surprises of 0% and 1.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Pediatrix Medical Group Reports Second Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Second Quarter Results
Mednax (MD) Reports Next Week: Wall Street Expects Earnings Growth
Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pediatrix Medical Group 2022 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 4, 2022
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2022 Second Quarter Conference Call/Webcast Scheduled for Thursday, August 4, 2022
2 Top Hospital Stocks to Buy Despite Industry Headwinds
Rising supplies expense, wages and benefits, and other operating costs are lowering margins for the Zacks Medical-Hospital industry players. However, Acadia Healthcare and Pediatrix Medical are poised t...
Ride on Rising P/E Investing With These 5 Top-Ranked Stocks
Want to try an out-of-the-box approach? Tap Oncolytics Biotech (ONCY), Pediatrix Medical Group Inc (MD), Boot Barn (BOOT), Canada Goose (GOOS) and Leap Therapeutics (LPTX).
Why Pediatrix Medical (MD) is a Solid Bet for Your Portfolio
Pediatrix Medical (MD) is expected to boost its services across maternal-fetal medicine, neonatology and obstetrics, plus 18 pediatric subspecialty offerings.
Will Mednax's (MD) New Name Pediatrix Medical be Beneficial?
Mednax's (MD) name change is expected to take effect following the closing bell on Jul 1, 2022.
Mednax To Change Name to Pediatrix Medical Group, Inc. Effective July 1, 2022
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax To Change Name to Pediatrix Medical Group, Inc. Effective July 1, 2022
Mednax Announces Leadership Appointments
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Announces Leadership Appointments
Mednax (MD) Down 20% Despite Q1 Earnings Beat on Patient Volumes
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
Mednax (MD) Q1 Earnings and Revenues Surpass Estimates
Mednax (MD) delivered earnings and revenue surprises of 22.22% and 1.75%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Mednax Reports First Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax Reports First Quarter Results
Covalon Announces New Senior Vice President of Marketing
MISSISSAUGA, ON , April 26, 2022 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that Ron Hebe...
Mednax 2022 First Quarter Conference Call/Webcast Scheduled for Thursday, April 28, 2022
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax 2022 First Quarter Conference Call/Webcast Scheduled for Thursday, April 28, 2022
Beyond MEME, 5 ETFs to Play Latest Reddit Craze
Meme stocks are those that hog attention of retail traders due to the hype surrounding them on online forums like Reddit. These stocks and ETFs could be played in order to tap the latest Reddit frenzy.
Is it the Right Time to Add Mednax (MD) Stock to Your Kitty?
Growing revenues, numerous acquisitions, diversified care network and adequate cash generation abilities are likely to continue driving Mednax (MD).
Should Value Investors Consider MEDNAX (MD) Stock Now?
Is MEDNAX (MD) a great pick from the value investor's perspective right now? Read on to know more.
4 Stocks to Watch From the Flourishing Hospital Industry
Rising patient volumes and the growing aging population are driving Zacks Medical-Hospital industry players' profits. HCA Healthcare, Universal Health, Tenet Healthcare and Mednax are poised to benefit ...
Here's How Mednax (MD) Can Gain By Adopting the Pediatrix Brand
Mednax (MD) bringing some of its operations under the Pediatrix brand is expected to collectively promote its wide range of healthcare services.
Mednax-Affiliated Practices to Adopt Pediatrix® Brand
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- #children--Mednax's affiliated practices will adopt the Pediatrix® brand, reflecting its role as the leading provider of care for women, babies and children.